Related Experiment Video
Updated: Dec 23, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway
Quan Hong1,2, Shuqiang Wang1,2, Shuxin Liu3,2
1Medical School of Chinese PLA, Beijing 100853, China.
Abstract:
Clear cell renal cell carcinoma (ccRCC) accounts for 60-70% of renal cell carcinoma (RCC) cases. It is an urgent mission to find more therapeutic targets for advanced ccRCC. Leucine-rich a-2-glycoprotein 1 (LRG1) is a secreted protein associated with a variety of malignancies. Our study focused on the expression and mechanism of LRG1 in ccRCC based on data from The Cancer Genome Atlas (TCGA) and provided primary verification including LRG1 expression detection, LRG1 gene methylation detection, and downstream signaling detection. We found that LRG1 was overexpressed in ccRCC kidney tissue samples, and the methylation level of LRG1 gene was significantly decreased in ccRCC. Moreover, the expression of LRG1 was negatively related to patient survival. Based on our previous study and the verification reported in this article, we propose that demethylation-induced overexpression of LRG1 is likely to accelerate ccRCC progression via the TGF-β pathway.
Related Concept Videos
TGF - β Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

